NPACT- Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase

Compound: 24-epibrassinolide

TargetsGene NameGene IDCancerCell LinesIC50ED50EC50GI50RemarkReferences
BCL2B-cell CLL/lymphoma 2596Breast adenocarcinomaMCF-7----Bcl-2 expression was slightly decreased after the 24-epiBL treatments (6, 12 and 24 h).20833159
BCL2B-cell CLL/lymphoma 2596Breast CarcinomaMDA-MB-468----In the MDA-MB-468 cells, Bcl-2 expression was slightly decreased after the 24-epiBL treatment (6, 12 and 24 h.20833159
BCL2L1BCL2-like 1598Breast adenocarcinomaMCF-7----24-epibrassinolide treatments caused expression of Bcl-XL proteins in MCF-7 cells to decrease after 12 h.20833159
BIDBH3 interacting domain death agonist637Breast adenocarcinomaMCF-7----Bid expression was slightly decreased after the 24-epiBL treatments (6 h).20833159
BIDBH3 interacting domain death agonist637Breast CarcinomaMDA-MB-468----MDA-MB-468 cells showed increased levels of reductions in uncleaved Bid expression only when subjected to 6 h of treatment.20833159
CASP3caspase 3, apoptosis-related cysteine peptidase836Breast CarcinomaMDA-MB-468----The blots showed degradation of caspase-3 into cleaved fragments (part of apoptotic cascade) after 24 h of 24-epibrassinolide treatment in MDA-MB-468 cells.20833159
CCNB1cyclin B1891Breast adenocarcinomaMCF-7----Expression levels of cyclin B1 protein were only slightly decreased following 24-epibrassinolide treatment in cancer cell lines.20833159
CCNB1cyclin B1891Breast CarcinomaMDA-MB-468----Expression levels of cyclin B1 protein were only slightly decreased following 24-epibrassinolide treatment in cancer cell lines.20833159
CCND1cyclin D1595Breast adenocarcinomaMCF-7----The expression of cyclins D1 was decreased in cell lines after 24-epibrassinolide treatment for 6, 12 or 24 .20833159
CCNE1cyclin E1898Breast adenocarcinomaMCF-7----The expression of E was decreased in cell lines after 24-epibrassinolide treatment for 6, 12 or 24 .20833159
CDK2cyclin-dependent kinase 21017Breast adenocarcinomaMCF-7----Reduction in CDK2 expression in cell lines was observed after 24 h of 24-epibrassinolide treatment.20833159
CDK2cyclin-dependent kinase 21017Breast CarcinomaMDA-MB-468----Reduction in CDK2 expression in cell lines was observed after 24 h of 24-epibrassinolide treatment.20833159
CDK4cyclin-dependent kinase 41019Breast adenocarcinomaMCF-7----Reduction in CDK4 expression in cell lines was observed after 24 h of 24-epibrassinolide treatment.20833159
CDK4cyclin-dependent kinase 41019Breast CarcinomaMDA-MB-468----Reduction in CDK4 expression in cell lines was observed after 24 h of 24-epibrassinolide treatment.20833159
CDKN1Acyclin-dependent kinase inhibitor 1A (p21, Cip1)1026Breast CarcinomaMDA-MB-468----significant increases in p21Waf1/Cip1 expression were observed after 12 and 24 h treatment with 24-epiBL.20833159
CDKN1Bcyclin-dependent kinase inhibitor 1B (p27, Kip1)1027Breast adenocarcinomaMCF-7----24-epiBL treatment of MCF-7 resulted in reductions in p27Kip1 expression after 6 and 12 h treatment.20833159
CDKN1Bcyclin-dependent kinase inhibitor 1B (p27, Kip1)1027Breast CarcinomaMDA-MB-468----p27Kip1 expression was decreased at all time points following the treatment of 24-epiBL.20833159
MDM2Mdm2, p53 E3 ubiquitin protein ligase homolog (mouse)4193Breast adenocarcinomaMCF-7----MCF-7 cella show decreased expression of MDM-2 after 6 h exposure to 24-epibrassinolide20833159
TP53tumor protein p537157Breast adenocarcinomaMCF-7----The MCF-7 cells showed a slight increase in p53 protein expression.20833159

 






Copyright © 2012. Subhash M. Agagrwal. All Rights Reserved.